Health
Combination of SFRP2 and PD-1 immunotherapy halts aggressive metastatic cancer in preclinical model – News-Medical.Net
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist…
In a cancer that has not seen new targeted therapies for over 20 years, MUSC Hollings Cancer Center researcher and oncologist Nancy Klauber-DeMore, M.D., is pioneering new discoveries.
Using a combination of personal passion and expertise, Klauber-DeMore…
Continue Reading
-
Business19 hours agoWhy Vault Minerals, Droneshield, Westgold Resources shares are climbing higher today
-
Noosa News20 hours agoQueensland’s nurses and midwives ramp up industrial action as pay negotiations break down
-
Noosa News20 hours agoQueensland racing, campdrafting events to continue after Hendra detection
-
Noosa News21 hours agoBroncos staffer who guided Mam through crash crisis admits to drink-driving